Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Oral Rinse for Oral Mucositis in Head and Neck Cancer
NCT06660017Phase 2Not yet recruiting
- Sponsor
- University of Oklahoma
- Start
- Dec 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 2, randomised trial of ketamine transdermal patch in oral mucositis (OM) (2 arms), sponsored by University of Oklahoma. Primary endpoint: Altered pain response from mucositis at 6 months. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
ketamine transdermal patch
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT06660017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06660017.